HBsAg:

Rex Wan-Hin Hui1, James Fung1,2, Wai-Kay Seto1,2

  • 1Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Road, Pok Fu Lam, Hong Kong.

PubMed
概括

新型组合疗法显示出在慢性乙型肝炎 (CHB) 中实现功能治愈的前景. 将RNA沉声器与免疫调节剂结合起来,可以增强HBsAg的衰减和免疫恢复,从而改变CHB的管理.